Search by Drug Name or NDC

    NDC 75987-0050-07 Ravicti 1.1 g/mL Details

    Ravicti 1.1 g/mL

    Ravicti is a ORAL LIQUID in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Horizon Therapeutics USA, Inc.. The primary component is GLYCEROL PHENYLBUTYRATE.

    Product Information

    NDC 75987-0050
    Product ID 75987-050_1e0214e6-fd39-4eec-a65d-3122f98b2c6e
    Associated GPIs 30908030000920
    GCN Sequence Number 070560
    GCN Sequence Number Description glycerol phenylbutyrate LIQUID 1.1GRAM/ML ORAL
    HIC3 D9A
    HIC3 Description AMMONIA INHIBITORS
    GCN 34137
    HICL Sequence Number 039990
    HICL Sequence Number Description GLYCEROL PHENYLBUTYRATE
    Brand/Generic Brand
    Proprietary Name Ravicti
    Proprietary Name Suffix n/a
    Non-Proprietary Name glycerol phenylbutyrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 1.1
    Active Ingredient Units g/mL
    Substance Name GLYCEROL PHENYLBUTYRATE
    Labeler Name Horizon Therapeutics USA, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203284
    Listing Certified Through 2024-12-31

    Package

    NDC 75987-0050-07 (75987005007)

    NDC Package Code 75987-050-07
    Billing NDC 75987005007
    Package 4 BOTTLE in 1 CARTON (75987-050-07) / 25 mL in 1 BOTTLE
    Marketing Start Date 2013-02-28
    NDC Exclude Flag N
    Pricing Information N/A